Significant Accounting Policies (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	May 09, 2019	May 08, 2019	Jan. 01, 2019	Dec. 31, 2018
Acquired IPR&D expense				$ 6,767,000
Derivative liability, fair value								$ 1,117,000
Right-of-use asset	$ 2,258,000		$ 2,258,000
Derivative, gain (loss) on derivative, net		$ (105,000)	1,117,000	$ (241,000)
Gain on change in fair value of derivative liabilities	$ 0
Restatement Adjustment [Member] | Accounting Standards Update 2016-02 [Member]
Lease liability							$ 3,800,000
Estimated incremental borrowing rate (as a percent)							15.00%
Right-of-use asset							$ 2,700,000
Synthetic Genomics Inc [Member] | C3J [Member]
Derivative liability, fair value					$ 0	$ 2,800,000
Derivative, gain (loss) on derivative, net			$ 2,000,000
Equity payment obligation			516,976